Industries > Pharma > Biopharmaceutical Excipients Market Report 2019-2029

Biopharmaceutical Excipients Market Report 2019-2029

By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), by Region and Segment Reports

PAGES: 164
PRODUCT CODE: PHA0511

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1

Biopharmaceutical Excipients is defined as the substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug (biologic) delivery system. The stability of large molecules is intrinsically inferior to small molecules. Research and investments made to address the challenges observed as a result of these facts should drive the market in the future. The profitable growth of the biopharmaceutical industry has created potential opportunities for conventional drug excipients developers to expand their business activities in this market. The market report describes the Biopharmaceutical Excipients such as the Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols and Carbohydrates.

Market Overview and Trends
The growth in this market can be attributed to factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals. Major companies are engaged in improvement of their manufacturing processes to comply with Goods Manufacturing Practice (GMP) requirements. Companies are also embracing initiatives to align with the regulations to achieve EXCiPACT certification which will create the huge impact on the whole industry from the forecast period of 2019-2029.

Factors Influencing the Market Growth:
• Growing pharmaceutical industry combined with advances in biopharmaceutical excipients
• Growing adoption of orphan drugs
• Increasing uptake of biopharmaceuticals
• Rise in outsourcing trend, novel production methods, and reduced timelines for product launches.

Factors Restraining the Market Growth:
• High production costs
• Time-intensive drug development process
• Increasing regulatory stringency

Market Segmentation 2019-2029:
The Biopharmaceutical Excipients market is segmented by Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts

Market Segmentation Covered:
• Global Biopharmaceutical Excipients Product Market 2019-2029
– Global Solubilizers & Surfactants/Emulsifiers Market 2019-2029
– Global Triglycerides Market 2019-2029
– Global Esters Market 2019-2029
– Global Others Market 2019-2029
– Global Polyols Market 2019-2029
– Global Mannitol Market 2019-2029
– Global Sorbitol Market 2019-2029
– Global Others Market 2019-2029
– Global Carbohydrates Market 2019-2029
– Global Sucrose Market 2019-2029
– Global Dextrose Market 2019-2029
– Global Starch Market 2019-2029
– Global Others Market 2019-2029
– Global Specialty Biopharmaceutical Excipients/Others Market 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Biopharmaceutical Excipients market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
ABITEC Corp.; Signet Chemical Corporation Pvt. Ltd.; Roquette; Sigachi Industries Pvt. Ltd.; Meggle AG; Colorcon, Inc.; DFE Pharma; Clariant; IMCD; SPI Pharma; Pharmonix Biological Pvt. Ltd.; Spectrum Chemical Manufacturing Corp., and BASF SE

Key questions answered by this report:
• What is the current size of the total global Biopharmaceutical Excipients market?
• How much will this market be worth from 2018 to 2029?
• How is the Biopharmaceutical Excipients market evolving?
• What is driving and restraining the Biopharmaceutical Excipients market?
• What are the market shares of each segment of the overall Biopharmaceutical Excipients market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Biopharmaceutical Excipients market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Biopharmaceutical Excipients market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Biopharmaceutical Excipients market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Biopharmaceutical Excipients market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Biopharmaceutical Excipients market. You find data, trends and predictions.

Buy our report today Biopharmaceutical Excipients Market 2019-2029: By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceutical Excipients Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceutical Excipients Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories